Peptide therapy TikTok claims: separating signal from hype

What's this video probably claiming?

Without a transcript, we're working from context, but peptide content on TikTok follows a pretty predictable pattern. Creators in this space almost always lead with recovery acceleration, particularly around BPC-157 and TB-500 as a stack for tendon and muscle repair. From there, the script typically moves to growth hormone secretagogues like CJC-1295 with ipamorelin for body recomposition, better sleep, and anti-aging. MK-677, which is actually a non-peptide ghrelin mimetic and not a true peptide despite frequent mislabeling, gets mentioned for muscle gain and GH pulse amplification. GHK-Cu shows up for skin and collagen claims. This creator appears to be doing a general overview or introduction to peptide therapy, possibly framing these compounds as accessible, low-risk performance tools. That framing deserves scrutiny.

What does the science actually show?

The honest answer: it depends heavily on which peptide you're asking about. BPC-157 has a legitimate preclinical base. Sikiric et al. (2018, Current Pharmaceutical Design) documented consistent tendon and gut healing effects in rodent models, but no peer-reviewed human RCT exists. TB-500, a synthetic thymosin beta-4 fragment, shows angiogenic and anti-inflammatory activity in animal studies (Goldstein et al., 2012, Annals of the New York Academy of Sciences), again without human trial data. CJC-1295 with ipamorelin was studied in healthy adults by Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism), showing meaningful GH pulse amplification at doses of 30-60 mcg/kg, but the long-term safety profile beyond 12 weeks is largely unknown. MK-677 has the most human data, including Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism), showing IGF-1 increases of roughly 40-60% in older adults but also significant insulin resistance signals. GHK-Cu human data is almost entirely limited to topical cosmetic studies.

Where does the social media noise diverge from clinical reality?

The biggest gap is the implied safety ceiling. Peptide TikTok routinely presents these compounds as categorically safer than anabolic steroids, which may be true for some, but is not a studied conclusion. Most of these peptides are not FDA-approved for the indications being discussed. BPC-157 and TB-500 have no approved human indication in the United States. The compounded versions circulating in the market have variable purity and bioavailability. A 2021 analysis published in Drug Testing and Analysis flagged significant dosing inconsistencies in commercially available research peptides. MK-677 being lumped in with peptides is a consistent mislabeling problem that matters clinically, since its mechanism is distinct and its risks, including edema, increased fasting glucose, and potential prolactin elevation, are underreported in creator content. The stack mentality, combining three or four of these compounds simultaneously, gets almost no critical treatment on social media despite the complete absence of combination safety data.

What should you actually know?

If you're considering peptide therapy, the regulatory and evidence context matters more than any single claim. The FDA has taken action against compounders producing BPC-157 and TB-500, and the legal landscape for access to these compounds has shifted significantly since 2023. That doesn't mean the science is useless. It means unsupervised self-administration based on TikTok protocols is a genuinely different risk category than physician-supervised use with pharmaceutical-grade compounds and monitoring. Semax and selank, both developed in Russia and used clinically there for cognitive and anxiolytic indications, have almost no English-language RCT data. Treating them as well-understood nootropics is not justified by the literature. The bottom line: some of these peptides have real mechanistic plausibility and early signal. None have the clinical trial depth to support the confident dosing and stacking protocols that dominate creator content in this category.